Vitamin D Receptor Polymorphism and Breast Cancer Risk: A Meta-Analysis

    loading  Checking for direct PDF access through Ovid


The objective was to perform a meta-analysis to summarize the available evidence from prospective nested case-control studies on the association of vitamin D receptor (VDR) polymorphism and the risk of breast cancer.We searched PubMed, ISI web of science, EMBASE, and reference lists for included articles. Study specific odds ratios (ORs) and 95% confidence intervals (CIs) were pooled by using fixed-effect or random-effects models.Eight studies were included in the meta-analysis. There were no association between Fok1 gene allele contrast f versus F (OR: 0.859; 95%CI: 0.685–1.079), ff versus FF (OR: 0.893; 95%CI: 0.763–1.045), recessive models ff versus FF+Ff (OR: 0.932; 95%CI: 0.796–1.092), and dominant models ff+Ff versus FF (OR: 0.899; 95%CI: 0.780–1.037). The estimated VDR polymorphism showed no significant association between Bsm1, Taq1, Apa1 polymorphism, and breast cancer risk. In the Caucasian ethnic subgroup, no association was found between allele contrast, recessive models, and dominant models on Fok1, Bsm1 polymorphism, and breast cancer risk.VDR polymorphism (Fok1, Bsm1, Taq1, and Apa1) were not associated with the risk of breast cancer in the general population as well as Caucasian population.

    loading  Loading Related Articles